Shareholder letter - Tuesday February 17, 2015
Link to document.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
May 27, 2016
RegeneRx Comments on Valuation
May 17, 2016
RegeneRx Releases Letter to Stockholders
April 28, 2016
RegeneRx and ReGenTree Expand License for Dry Eye